BPLBSEBPL LtdMinimalNeutral
Announced Sat, 30 May · 14:00 IST

ASCR 2026

BPL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.7%1-day move
₹54.34
prior close
₹55.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7-1.5-2.3-2.3-1.7-3.4-5.1-3.9-5.7-4.5+10.0+4.9
Up moveDown movePending
AI summary

BPL Limited has filed its Annual Secretarial Compliance Report for FY ended March 31, 2026, prepared by Practicing Company Secretary Madhwesh Prathap and Associates. The report identifies 5 material compliance deviations, all related to Related Party Transactions (RPTs) under Regulation 23 of LODR. Key violations include a material RPT (ER Computer borrowing > Rs. 1 crore) that occurred on 12 September 2025 but received audit committee approval only on 7 November 2025 (retrospective), and EGM shareholder approval obtained on 11 November 2025 — both after the transaction date. The material RPT was also not disclosed in the half-yearly integrated financials for the period ending 30 September 2025. Additionally, audit committee approval dates were not provided for multiple RPTs with related parties including BPL Medical Technologies, BPL Telecom, and Electronic Research Private Limited. Half-yearly RPT data has not been uploaded to the company's website. An Integrated Governance Report discrepancy was also noted — director re-appointment dates for Mr. Chandan Juneja and Mr. Nowroz J Cama (reappointed in June 2025 EGM) were not updated in subsequent quarterly filings. No penalties or show-cause notices have been issued by SEBI or the stock exchanges so far.

Likely market impact

The company has multiple lapses in RPT compliance and disclosure — particularly the timing of approvals for a material related party transaction — which raise governance concerns. No fines have been imposed yet, but the stock exchange may review the report. Shareholders should monitor for any regulatory action.